RECENTROL Trademark

Trademark Overview

On Wednesday, October 18, 2006, a trademark application was filed for RECENTROL with the United States Patent and Trademark Office. The USPTO has given the RECENTROL trademark a serial number of 77023985. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 5, 2009. This trademark is owned by ASTRAZENECA UK LIMITED. The RECENTROL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in the treatment of cancer
recentrol

General Information

Serial Number77023985
Word MarkRECENTROL
Filing DateWednesday, October 18, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 5, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 4, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 23, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameASTRAZENECA UK LIMITED
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLondon W1K1LN
GB
Party NameASTRAZENECA UK LIMITED
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLondon W1K1LN
GB

Trademark Events

Event DateEvent Description
Monday, October 5, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 5, 2009ABANDONMENT - NO USE STATEMENT FILED
Friday, February 13, 2009EXTENSION 2 GRANTED
Wednesday, February 11, 2009EXTENSION 2 FILED
Wednesday, February 11, 2009TEAS EXTENSION RECEIVED
Wednesday, August 20, 2008EXTENSION 1 GRANTED
Friday, August 8, 2008EXTENSION 1 FILED
Wednesday, August 20, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 8, 2008TEAS EXTENSION RECEIVED
Tuesday, March 4, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, January 18, 2008EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, October 4, 2007EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 4, 2007PUBLISHED FOR OPPOSITION
Wednesday, August 15, 2007NOTICE OF PUBLICATION
Thursday, June 7, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 7, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 24, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 21, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, May 13, 2007EXAMINER'S AMENDMENT ENTERED
Friday, May 11, 2007ASSIGNED TO LIE
Friday, May 11, 2007ASSIGNED TO LIE
Friday, May 11, 2007EXAMINERS AMENDMENT E-MAILED
Friday, May 11, 2007EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 6, 2007NON-FINAL ACTION E-MAILED
Tuesday, March 6, 2007NON-FINAL ACTION WRITTEN
Friday, March 2, 2007ASSIGNED TO EXAMINER
Monday, October 23, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

recentrol cancer treatment substances preparations pharmaceutical